# Epoetin theta

Source: https://onco.cc/drugs/epoetin-theta/  
OnCo record `epoetin-theta` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Epoetin theta is a made-to-order version of erythropoietin, the hormone that tells the marrow to make red blood cells. It is used to treat the anaemia of chemotherapy in people with non-myeloid cancers, sparing some transfusions.

## Summary

Epoetin theta is authorised in the EU under two names: Biopoin (authorised 23 October 2009; marketing authorisation holder Teva GmbH) and Eporatio (authorised 29 October 2009; marketing authorisation holder Ratiopharm GmbH, a Teva company per Wikidata Q265318). Both are indicated for symptomatic anaemia associated with chronic renal failure in adults and for symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy. The corpus's other erythropoiesis-stimulating agents are epoetin alfa and darbepoetin alfa.

## Fields

- Kind: Treatment
- Status: approved
- Last checked: 2026-09-22
- Also known as: epoetin theta; Eporatio; Biopoin
- Tags: ema-register; supportive
- Brand: Eporatio / Biopoin
- Modality: Recombinant erythropoietin (erythropoiesis-stimulating agent)
- Mechanism: Recombinant human erythropoietin that acts on the erythropoietin receptor to stimulate red-cell production; used for symptomatic anaemia in adults with non-myeloid cancers receiving chemotherapy and in chronic renal failure (indication wording, EMA).
- Approvals: EU 2009: Symptomatic anaemia in adult cancer patients with non-myeloid malignancies receiving chemotherapy; anaemia of chronic renal failure

## Sources

- EMA: Eporatio (EPAR): https://www.ema.europa.eu/en/medicines/human/EPAR/eporatio
- EMA: Biopoin (EPAR): https://www.ema.europa.eu/en/medicines/human/EPAR/biopoin

## Connected records

- drugs: [Darbepoetin alfa](https://onco.cc/drugs/darbepoetin-alfa/), [Epoetin alfa](https://onco.cc/drugs/epoetin-alfa/)
- technologies: [Transfusion support and anaemia management](https://onco.cc/technologies/transfusion-support/)
- targets: [Erythropoietin receptor (EPOR)](https://onco.cc/targets/epor/)
- companies: [Teva Pharmaceuticals](https://onco.cc/companies/teva/)

---
JSON: https://onco.cc/api/v1/entities/epoetin-theta.json